Used in solid-phase peptide synthesis as a protected amino acid derivative, enabling the incorporation of rigid, conformationally constrained residues into peptide chains. Its Fmoc group allows for mild base deprotection, compatible with standard Fmoc/tBu strategies. The tetrahydroisoquinoline scaffold provides structural stability and is often utilized in the development of bioactive peptides, enzyme inhibitors, and peptidomimetics, particularly in pharmaceutical research targeting neurological disorders and cancer. Its aromatic and chiral nature supports selective interactions with biological targets, making it valuable in drug design and combinatorial chemistry.